Partner Event:
China Healthcare Summit
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.


Written by Richard Daverman, PhD.

Click a link below to view the mailing archive as if it had been sent to you.

2011-06-30 01:30Wuhan Kindstar Diagnostics Raises $11 Million in Series B Funding and more...
2011-06-29 01:30Biotech a Priority in China's $309 Billion Five-Year Plan and more...
2011-06-28 01:30Microbix and Hunan Influenza JV Looking Doubtful
2011-06-26 01:30The Week in Review: Sihuan Pharma Uses M&A to Add Vascular Drugs
2011-06-25 01:30J&J Opens Innovation Center for Medical Devices in Suzhou and more...
2011-06-24 01:30Sirnaomics Names China Partner for siRNA Therapeutic and more...
2011-06-23 01:30Shandong Jincheng Pharma Completes $72 Million IPO and more...
2011-06-22 01:30Britain and China Announce $155 Million Drug Development Partnership and more...
2011-06-21 01:30Biomatters Partners with Genewiz; Plans Entry into China and more...
2011-06-19 01:30The Week in Review: GSK Buys Out China Vaccine JV Partner
2011-06-18 01:30CRO ClinTec Making Push into China and Asia Pacific Region and more...
2011-06-17 01:30LabCorp Buys Clearstone Labs, Giving it Access to China and more...
2011-06-16 01:30Nycomed to Market Roche Osteoporosis Drug in China and Asia-Pacific
2011-06-15 01:30GlaxoSmithKline to Buy Out China Vaccine JV Partner and more...
2011-06-14 01:30Unigene Ends China Peptide JV; Will Out-License Technology and more...
2011-06-12 01:30The Week in Review: Northeast Pharma of China to Raise $370 Million
2011-06-11 01:30NDAs and INDs Quantify the Innovation in China's Drug R&D
2011-06-10 01:30Harbor BioSciences in Deal for ex-China Distribution of Sinopharm Generics and more...
2011-06-09 01:30Selected Value Therapeutics Acquires China Rights to Cancer Drug and more...
2011-06-08 01:30Simcere Receives Settlement for Shuttered Rabies Vaccine Facility and more...
2011-06-07 01:30Foci Pharma Seeks EU Approval of TCM
2011-06-05 01:30The Week in Review: Tasly Pharma to Build US Manufacturing Facility
2011-06-04 01:30Zhejiang Huahai Obtains FDA Approval for Alzheimer's Drug and more...
2011-06-03 01:30Tasly Pharma to Make $40 Million Investment in US Facility and more...
2011-06-02 01:30Livzon Pharma to Spend $154 Million on New API Facilities and more...
2011-06-01 01:30All 11 Defendants Plead Guilty in Fake Avastin Case and more...

 

<< Archive IndexSubscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC